Rockefeller Capital Management L.P. reduced its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 9.0% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 479,020 shares of the company’s stock after selling 47,459 shares during the quarter. Eli Lilly and Company comprises […]

Kingfisher Capital LLC lowered its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 3.4% in the third quarter, HoldingsChannel reports. The fund owned 10,640 shares of the company’s stock after selling 378 shares during the period. Eli Lilly and Company accounts for approximately 2.2% of Kingfisher Capital LLC’s investment portfolio, […]

Carl P. Sherr & Co. LLC boosted its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 0.4% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,526 shares of the company’s stock after purchasing an additional 24 shares during the […]

WorthPointe LLC grew its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 77.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 469 shares of the company’s stock after acquiring an additional 204 shares during the period. […]

Glenmede Trust Co. NA trimmed its stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 1.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 356,296 shares of the company’s stock after selling 5,297 shares during the quarter. […]

Cadence Bank cut its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 8.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,811 shares of the company’s stock after selling 1,117 shares during the period. Cadence Bank’s holdings in […]